New Parkinson’s treatment described as potential ‘game-changer’


This potential breakthrough stems from a recent clinical trial led by neurologist and professor Thomas Foltynie in the United Kingdom. In the course of a 48-week period, Parkinson’s patients who received the drug exenatide retained more motor function than patients who received a placebo.
Read more http://www.mlive.com/news/grand-rapids/index.ssf/2017/09/parkinsons_specialists_gather.html

 

Exenatide: One step closer to joblessness!

http://journals.lww.com/neurotodayonline/blog/breakingnews/pages/post.aspx?PostID=642